|
Volumn 411, Issue 1-2, 2001, Pages 187-192
|
Pharmacological properties of a newly synthesized H+/K+ ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-[(3-hydroxypropyl)amino]-6-methyl-2,3-dihyd ropyrrolo[3,2-c]quinoline
|
Author keywords
Anti ulcer activity; Duodenal ulcer; Gastric acid secretion; Gastric ulcer
|
Indexed keywords
2,3 DIHYDRO 4 (3 HYDROXYPROPYLAMINO) 1 (4 METHOXY 2 METHYLPHENYL) 6 METHYLPYRROLO[3,2 C]QUINOLINE;
ACETYLSALICYLIC ACID;
ALCOHOL;
HISTAMINE;
INDOMETACIN;
MERCAPTAMINE;
OMEPRAZOLE;
PENTAGASTRIN;
PROTON PUMP INHIBITOR;
SODIUM HYDROXIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CONTROLLED STUDY;
DOSE RESPONSE;
DUODENUM ULCER;
MALE;
NONHUMAN;
PEPTIC ULCER;
PRIORITY JOURNAL;
RAT;
STOMACH ACID SECRETION;
STOMACH FISTULA;
STOMACH LESION;
ANIMALS;
ANTI-ULCER AGENTS;
ASPIRIN;
CYSTEAMINE;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENZYME INHIBITORS;
ETHANOL;
GASTRIC ACID;
H(+)-K(+)-EXCHANGING ATPASE;
INDOMETHACIN;
OMEPRAZOLE;
PERFUSION;
PYRROLES;
QUINOLINES;
RATS;
RATS, SPRAGUE-DAWLEY;
SODIUM HYDROXIDE;
STOMACH;
STOMACH ULCER;
TIME FACTORS;
|
EID: 0035187862
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(00)00920-1 Document Type: Article |
Times cited : (9)
|
References (12)
|